Residual muscle-invasive disease at cystectomy is not accurately predicted by post-chemotherapy restaging protocols including DNA damage response gene mutation analysis

by R.E.N. Becker, A. Baras, A.R. Meyer, A. Brant, A.C. Reese, G.J. Netto, A. Matoso, J.H. Hoffman-Censits, N.M. Hahn, W. Choi, D.J. McConkey, P.M. Pierorazio, M.H. Johnson, M.P. Schoenberg, M.R. Kates, T.J. Bivalacqua
Published 2020-07-01